Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib

In conclusion, the proteinuria grade was not significantly associated with decreased eGFR under UPCR monitoring in our study. Therefore, lenvatinib can carefully be continued targeting UPCR of less than 3.5 g/gCre.PMID:38296547 | DOI:10.1507/endocrj.EJ23-0378

Source: Endocrine Journal - January 31, 2024 Category: Endocrinology Authors: Naoki Fukuda Kazuhisa Toda Hirotaka Suto Ryosuke Oki Xiaofei Wang Tetsuya Urasaki Yasuyoshi Sato Kenji Nakano Makiko Ono Junichi Tomomatsu Hiroki Mitani Shunji Takahashi Source Type: research